Patents Assigned to Eriochem USA, LLC
  • TARGETED DRUG DELIVERY AND THERAPEUTIC METHODS USING APO-E MODIFIED LIPID NANOPARTICLES
    Publication number: 20190307892
    Abstract: Methods for targeted delivery of therapeutic agents to a target cell or tissue with lipid nanoparticles comprising ApoE3. In embodiments, the invention specifically relates to targeted delivery of anticancer drugs, antibiotics, antifungal drugs, and diagnostic contrast agents, and associated treatment and diagnostic methods. In embodiments, diseases/conditions treated include those associated with over-expression of LDL receptors.
    Type: Application
    Filed: April 4, 2018
    Publication date: October 10, 2019
    Applicant: Eriochem USA, LLC
    Inventors: Jose Lucio Nunez, Dante Selenscig, Maria de los Angeles Ramirez
  • APO-E MODIFIED LIPID NANOPARTICLES FOR DRUG DELIVERY TO TARGETED TISSUES AND THERAPEUTIC METHODS
    Publication number: 20190046446
    Abstract: Lipid nanoparticles and methods of making and using the same, including pharmaceutical compositions and kits, and the targeted delivery of drugs in various treatment methods. The nanoparticle formulation includes phospholipids, triglycerides, cholesterol, cholesteryl ester, apolipoprotein E3 (ApoE3), and a lipophilic therapeutic agent.
    Type: Application
    Filed: September 28, 2017
    Publication date: February 14, 2019
    Applicant: Eriochem USA, LLC
    Inventors: Jose Lucio NUNEZ, Dante SELENSCIG, Maria de los Angeles RAMIREZ